Bionano Genomics, Inc.

NASDAQ:BNGO

0.2 (USD) • At close December 20, 2024
Bedrijfsnaam Bionano Genomics, Inc.
Symbool BNGO
Munteenheid USD
Prijs 0.195
Beurswaarde 19,888,635
Dividendpercentage 0%
52-weken bereik 0.195 - 2.27
Industrie Diagnostics & Research
Sector Healthcare
CEO Dr. Robert Erik Holmlin M.B.A., Ph.D.
Website https://www.bionanogenomics.com

An error occurred while fetching data.

Over Bionano Genomics, Inc.

Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and

Vergelijkbare Aandelen

Vera Therapeutics, Inc. logo

Vera Therapeutics, Inc.

VERA

42.6 USD

908 Devices Inc. logo

908 Devices Inc.

MASS

2.06 USD

CareMax, Inc. logo

CareMax, Inc.

CMAX

0.422 USD

Cara Therapeutics, Inc. logo

Cara Therapeutics, Inc.

CARA

0.423 USD

Arcturus Therapeutics Holdings Inc. logo

Arcturus Therapeutics Holdings Inc.

ARCT

15.48 USD

Alpha Tau Medical Ltd. logo

Alpha Tau Medical Ltd.

DRTS

3.1 USD

Day One Biopharmaceuticals, Inc. logo

Day One Biopharmaceuticals, Inc.

DAWN

12.79 USD

2seventy bio, Inc. logo

2seventy bio, Inc.

TSVT

3.14 USD

Nautilus Biotechnology, Inc. logo

Nautilus Biotechnology, Inc.

NAUT

1.76 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)